Rami Doukky

Rami Doukky

Auto-generated profile, based on publicly available information

Rami Doukky

Division of Cardiology, Cook County Health, Chicago, IL; Division of Cardiology, Rush University Medical Center, Chicago, IL

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2013 in Circulation
Verified
Journal Article
Closed access
RDRami Doukky
Rami Doukky
KHKathleen Hayes
Kathleen Hayes
NFNathan Frogge
Nathan Frogge
GBGautam Balakrishnan
Gautam Balakrishnan
VDVenkata Satish Dontaraju
Venkata Satish Dontaraju
RHRobert C. Hendel
Robert C. Hendel
Background—: Appropriate use criteria (AUC) have been developed to aid in the optimal use of single-photon emission computed tomography (SPECT)–myocardial perfusion imaging (MPI), a technique that is a mainstay of risk assessment for ischemic heart disease. The impact of appropriate use on the prognostic value of SPECT-MPI is unknown. Methods and Results—: A prospective cohort study of 1511 consecutive patients undergoing outpatient, community-based SPECT-MPI was conducted. Subjects were stratified on the basis of the 2009 AUC for SPECT-MPI into an appropriate or uncertain appropriateness group and an inappropriate group. Patients were prospectively followed up for 27±10 months for major adverse cardiac events of death, death or myocardial infarction, and cardiac death or myocardial infarction. In the entire cohort, the 167 subjects (11%) with an abnormal scan experienced significantly higher rates of major adverse cardiac events and coronary revascularization than those with normal MPI. Among the 823 subjects (54.5%) whose MPIs were classified as appropriate (779, 51.6%) or uncertain (44, 2.9%), an abnormal scan predicted a multifold increase in the rates of death (9.2% versus 2.6%; hazard ratio, 3.1; P =0.004), death or myocardial infarction (11.8% versus 3.3%; hazard ratio, 3.3; P =0.001), cardiac death or myocardial infarction (6.7% versus 1.7%; hazard ratio, 3.7; P =0.006), and revascularization (24.7% versus 2.7%; hazard ratio, 11.4; P <0.001). Among the 688 subjects (45.5%) with MPI classified as inappropriate, an abnormal MPI failed to predict major adverse cardiac events, although it was associated with a high revascularization rate. Furthermore, appropriate MPI use provided incremental prognostic value beyond myocardial perfusion and ejection fraction data. Conclusions—: When performed for appropriate indications, SPECT-MPI continues to demonstrate high prognostic value. However, inappropriate use lacks effectiveness for risk stratification, further emphasizing the need for optimal patient selection for cardiac testing.

1 January 2016 in JACC: Heart Failure
Verified
Journal Article
Closed access
RDRami Doukky
Rami Doukky
EAElizabeth Avery
Elizabeth Avery
AMAshvarya Mangla
Ashvarya Mangla
FCFareed M. Collado
Fareed M. Collado
ZIZeina Ibrahim
Zeina Ibrahim
LPLynda H. Powell
Lynda H. Powell

1 April 2016 in The American Journal of Cardiology
Verified
Journal Article
Closed access
RDRami Doukky
Rami Doukky
AMAshvarya Mangla
Ashvarya Mangla
ZIZeina Ibrahim
Zeina Ibrahim
MPMarie-France Poulin
Marie-France Poulin
EAElizabeth Avery
Elizabeth Avery
LPLynda H. Powell
Lynda H. Powell

1 June 2012 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
PDF file
RDRami Doukky
Rami Doukky
RDRaysa Morales Demori
Raysa Morales Demori
SJSidharth Jain
Sidharth Jain
RKRoy Kiriakos
Roy Kiriakos
VMVictor Mwansa
Victor Mwansa
JCJames E. Calvin
James E. Calvin

1 April 2013 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
PDF file
RDRami Doukky
Rami Doukky
MRMaria Octavia Rangel
Maria Octavia Rangel
MWMarwan Wassouf
Marwan Wassouf
RDRizcallah Dick
Rizcallah Dick
AAAmmar Alqaid
Ammar Alqaid
RDRaysa Morales Demori
Raysa Morales Demori

1 October 2013 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
PDF file
RDRami Doukky
Rami Doukky
NFNathan Frogge
Nathan Frogge
YBYohannes A. Bayissa
Yohannes A. Bayissa
GBGautam Balakrishnan
Gautam Balakrishnan
JSJacob M. Skelton
Jacob M. Skelton
RKRussell F. Kelly
Russell F. Kelly